# Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer

> **NCT01342367** · NA · ACTIVE_NOT_RECRUITING · sponsor: **University of Chicago** · enrollment: 74 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Bicalutamide
- **DRUG:** Dutasteride
- **DRUG:** Finasteride
- **RADIATION:** Radiation

## Key facts

- **NCT ID:** NCT01342367
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2010-12-17
- **Primary completion:** 2020-05-01
- **Final completion:** 2026-02
- **Target enrollment:** 74 (ACTUAL)
- **Last updated:** 2025-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01342367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01342367, "Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01342367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*